Patients are participating in leukaemia research around the world

We currently have a number of clinical trials and research studies seeking patients with leukaemia. We can help find trials and research studies near you and may help you to get access to those opportunities.

Find a medical research participation opportunity that is right for you!

Leukaemia clinical trials and research studies

Leukaemia is the general name given to a group of cancers that develop in blood-forming cells, which begin in the bone marrow. The majority of cases of leukaemia originate in white blood cells. Cancer occurs when certain and important genes are affected by changes called mutations. These affected genes typically oversee cell growth or cell death, and these mutations often lead to cells multiplying in an uncontrolled manner. Many people with leukaemia have no symptoms. When symptoms do develop, they tend to be mild at first and worsen slowly. These include anaemia, tiredness, repeated infections, and bruising and bleeding. Both adults and children can develop leukaemia but specific types are more common in certain age groups. Treatments can include surgery, bone marrow transplant, chemotherapy, radiotherapy and targeted therapies.

With the five-year survival rate being around 60% in many countries, there is intense research into understanding how leukaemia develops and how we may be able to prevent it, as well as into developing better treatments, particularly for the types of leukaemia that can be or become drug resistant. Leukaemia researchers are leading the way in developing targeted therapies to treat the disease.

Participating in leukaemia research and clinical trials may be a method to access the latest treatment drugs or it may help pave the way in developing new therapies that will benefit others. There are a large number of clinical trials and research studies undertaken each year to understand, prevent and treat leukaemia.

Participants participated for leukaemia trials around the world

Opin’s direct-to-patient approach can reduce participant timelines to weeks, not months.

Number of Participants

required for trials.

* out of total trials participating

Leukaemia clinical trials and research studies around the world

482 trials

Phase 1

300 trials

Phase 2

77 trials

Phase 3

17 trials

Phase 4

267 trials


Leading areas of leukaemia research

Types of leukaemia